Thierry Imbert

USPTO Granted Patents = 22 (Patent Applications = 4)

CIPO Patents = 4

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 56(Granted Patents)

Company Filing History:

20 out of 266

Pierre Fabre Medicament

patents

1 out of 5,069

Centre National De La Recherche Scientifique

patents

2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2016

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9439982 - Fluorescent cyanine-polyamine derivatives as a diagnostic probe (2016-09-13),

2. 9403840 - (Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents (2016-08-02),

3. 9216989 - (Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents (2015-12-22),

4. 8664409 - Process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin useful for their applications in therapeutics as anticancer agent (2014-03-04),

5. 8569011 - Fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumors (2013-10-29),

6. 8546402 - Chromone derivatives, a process for their preparation and their therapeutic applications (2013-10-01),

7. 8492567 - (Poly)Aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents (2013-07-23),

8. 8288567 - (Poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents (2012-10-16),

9. 8193379 - Method for preparing 4B-amino-4'-demethyl-4-desoxypodophyllotoxin (2012-06-05),

10. 8148552 - Process for the synthesis of anticancer (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin (2012-04-03),

11. 7932406 - Method for preparing 4β-amino-4'-demethyl-4-desoxypodophyllotoxin (2011-04-26),

12. 7846926 - (Poly)aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents (2010-12-07),

13. 7456192 - 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof (2008-11-25),

14. 6610725 - Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof (2003-08-26),

15. 6153638 - Use of efaroxan for producing medicine for treating huntington 's disease (2000-11-28),

Title: Thierry Imbert: Innovator in Cancer Diagnostics and Therapeutics

Introduction

Thierry Imbert, an esteemed inventor based in Viviers les Montagnes, France, has made significant contributions to the fields of diagnostics and therapeutics, particularly concerning cancer treatment. With an impressive portfolio of 22 patents, he stands as a key figure in the innovation landscape.

Latest Patents

Among Imbert's latest inventions are groundbreaking patents that hold promising applications in cancer diagnostics. One such patent is for "Fluorescent Cyanine-Polyamine Derivatives as a Diagnostic Probe." This invention relates to fluorescent derivatives of cyanines conjugated with a polyamine group, which can serve as diagnostic probes for detecting cancer tumors in vivo. Furthermore, his work on "(Poly) Aminoacetamide Derivatives of Epipodophyllotoxin: Their Process of Preparation and Their Applications in Therapeutics as Anticancer Agents" introduces novel podophyllotoxin derivatives, emphasizing their therapeutic potential as anticancer agents.

Career Highlights

Imbert has been associated with reputable companies, including Pierre Fabre Medicament, where he has honed his expertise in pharmaceutical innovations. His extensive research and development work have significantly advanced the understanding and treatment of cancer, solidifying his reputation as a leading figure in medical innovation.

Collaborations

Through his career, Imbert has collaborated with notable colleagues such as Yves Guminski and Jean-Marc Barret. These collaborations have fostered a rich environment for creativity and innovation, contributing to the success of his projects and inventions.

Conclusion

Thierry Imbert's work is a testament to the power of innovation in addressing complex medical challenges. With a focus on developing diagnostic and therapeutic solutions for cancer, his contributions continue to pave the way for new advancements in the medical field. As an inventor, his legacy will undoubtedly inspire future generations of researchers and innovators.

This text is generated by artificial intelligence and may not be accurate.